, a bio/informatics shared resource is still "open for business" - Visit the CDS website


  1. Quantitative and qualitative differences in the in vivo response of NKT cells to distinct alpha- and beta-anomeric glycolipids. Parekh VV, Singh AK, Wilson MT, Olivares-Villagómez D, Bezbradica JS, Inazawa H, Ehara H, Sakai T, Serizawa I, Wu L, Wang CR, Joyce S, Van Kaer L (2004) J Immunol 173(6): 3693-706
    › Primary publication · 15356115 (PubMed)
  2. Quantitative and qualitative differences in proatherogenic NKT cells in apolipoprotein E-deficient mice. Major AS, Wilson MT, McCaleb JL, Ru Su Y, Stanic AK, Joyce S, Van Kaer L, Fazio S, Linton MF (2004) Arterioscler Thromb Vasc Biol 24(12): 2351-7
    › Primary publication · 15472130 (PubMed)
  3. Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. Diao H, Kon S, Iwabuchi K, Kimura C, Morimoto J, Ito D, Segawa T, Maeda M, Hamuro J, Nakayama T, Taniguchi M, Yagita H, Van Kaer L, Onóe K, Denhardt D, Rittling S, Uede T (2004) Immunity 21(4): 539-50
    › Primary publication · 15485631 (PubMed)
  4. NKT cells: what's in a name? Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L (2004) Nat Rev Immunol 4(3): 231-7
    › Primary publication · 15039760 (PubMed)
  5. NK cells, but not NKT cells, are involved in Pseudomonas aeruginosa exotoxin A-induced hepatotoxicity in mice. Mühlen KA, Schümann J, Wittke F, Stenger S, Van Rooijen N, Van Kaer L, Tiegs G (2004) J Immunol 172(5): 3034-41
    › Primary publication · 14978108 (PubMed)
  6. NF-kappa B controls cell fate specification, survival, and molecular differentiation of immunoregulatory natural T lymphocytes. Stanic AK, Bezbradica JS, Park JJ, Matsuki N, Mora AL, Van Kaer L, Boothby MR, Joyce S (2004) J Immunol 172(4): 2265-73
    › Primary publication · 14764695 (PubMed)
  7. Natural killer T cells as targets for immunotherapy of autoimmune diseases. Van Kaer L (2004) Immunol Cell Biol 82(3): 315-22
    › Primary publication · 15186263 (PubMed)
  8. Natural killer T cells accelerate atherogenesis in mice. Nakai Y, Iwabuchi K, Fujii S, Ishimori N, Dashtsoodol N, Watano K, Mishima T, Iwabuchi C, Tanaka S, Bezbradica JS, Nakayama T, Taniguchi M, Miyake S, Yamamura T, Kitabatake A, Joyce S, Van Kaer L, Onoé K (2004) Blood 104(7): 2051-9
    › Primary publication · 15113755 (PubMed)
  9. Differential requirement for tapasin in the presentation of leader- and insulin-derived peptide antigens to Qa-1b-restricted CTLs. Li L, Sullivan BA, Aldrich CJ, Soloski MJ, Forman J, Grandea AG, Jensen PE, Van Kaer L (2004) J Immunol 173(6): 3707-15
    › Primary publication · 15356116 (PubMed)
  10. Cutting edge: the ontogeny and function of Va14Ja18 natural T lymphocytes require signal processing by protein kinase C theta and NF-kappa B. Stanic AK, Bezbradica JS, Park JJ, Van Kaer L, Boothby MR, Joyce S (2004) J Immunol 172(8): 4667-71
    › Primary publication · 15067039 (PubMed)